
Private Equity Owns Your Life Insurance Company. Should You Be Worried?
Over the past decade, one of the most significant shifts in financial services has happened largely out of public view.
Private equity firms have quietly become major players in the life insurance industry.
Companies such as Apollo, KKR, Carlyle, and Blackstone now control or influence billions of dollars in life insurance assets. What started as a niche investment strategy has evolved into a major transformation of how insurance companies invest, grow, and manage risk.
For some observers, this trend represents innovation and efficiency.
For others, it raises uncomfortable questions about risk, transparency, and the future stability of the life insurance industry.
So who is right?
How Private Equity Entered the Insurance Business
The modern era began when Apollo acquired a life insurance platform that eventually became what investors know today as Athene.
The logic was straightforward.
Life insurance companies collect premiums today in exchange for promises that may not need to be paid for decades. That creates enormous pools of long-term capital.
For private equity firms, these liabilities looked like an ideal funding source.
Instead of relying solely on investors to provide capital, insurance companies offered access to what many alternative asset managers call "permanent capital."
The opportunity was enormous.
Since then, KKR acquired Global Atlantic, Carlyle established its own insurance partnerships, and Blackstone built investment management relationships with multiple insurers.
Today, the relationship between alternative asset managers and life insurance companies is one of the most important trends in modern finance.
Why Private Equity Loves Insurance
The attraction is not complicated.
Traditional life insurers have historically invested conservatively.
Their portfolios typically consist of government bonds, investment-grade corporate debt, and other low-risk securities designed to preserve capital rather than maximize returns.
Private equity firms believe they can do better.
By investing in private credit, structured securities, asset-backed lending, infrastructure projects, and other alternative assets, they aim to generate higher yields than traditional insurers.
Even a modest increase in portfolio returns can have a massive impact when managing hundreds of billions of dollars.
In many cases, earning an additional 1% annually on a large insurance portfolio translates into billions of dollars of additional value over time.
That advantage can then feed directly into the private equity firm's asset management business through management fees and new investment opportunities.
Are They Taking More Risk?
This is where the debate becomes interesting.
Critics argue that private equity-owned insurers are reaching for yield by taking excessive risk.
Supporters argue that they are simply investing more efficiently than traditional insurers.
The reality appears to be somewhere in the middle.
Research suggests that alternative-manager-owned insurers typically earn roughly 100 basis points more yield than traditional life insurance companies.
The question is how they achieve those higher returns.
According to industry analysts, much of the additional yield comes from:
Private credit investments
Structured securities
Asset-backed lending
Higher concentration in select investments
Greater willingness to accept illiquidity
Importantly, this does not necessarily mean these firms are making reckless bets.
The largest alternative managers often have extensive credit expertise and sophisticated risk management capabilities.
However, they are generally more comfortable investing in areas that traditional insurers have historically avoided.
The Reinsurance Question
One of the most controversial aspects of the industry involves reinsurance.
Reinsurance allows insurers to transfer portions of their liabilities to another entity.
In many cases, insurers create captive reinsurance companies in jurisdictions such as Bermuda.
Critics argue that these structures reduce transparency and may allow companies to hold less capital than would otherwise be required.
Supporters argue that U.S. insurance regulations are excessively conservative and that reinsurance simply allows companies to operate more efficiently.
Bermuda has become a major center for these transactions because its regulatory framework is designed specifically for insurance and reinsurance businesses.
Some observers are now paying attention to newer jurisdictions such as the Cayman Islands, where regulations may be perceived as more flexible.
While concerns exist, there is currently limited evidence suggesting widespread abuse of these structures.
The debate remains ongoing.
The Industry's Long History of Risk Management Failures
To understand why investors remain skeptical of life insurance companies, it helps to examine their history.
Over the last three decades, the industry has experienced multiple waves of self-inflicted crises.
Three products caused particularly severe damage:
1. Long-Term Care Insurance
Long-term care insurance became one of the biggest disasters in modern insurance history.
Companies assumed:
Policyholders would frequently cancel policies
Interest rates would remain relatively high
Claims would remain short in duration
All three assumptions proved wrong.
People kept their policies.
Interest rates collapsed.
Medical advances allowed individuals to live longer while requiring years of expensive care.
The result was billions of dollars in unexpected losses.
Some companies spent decades absorbing the consequences.
2. Variable Annuities
Variable annuities offered customers attractive guarantees linked to investment performance.
The problem was that many insurers hedged long-term liabilities using short-term derivatives.
When market volatility exploded during the Global Financial Crisis, hedging costs skyrocketed.
Many companies discovered that their risk management strategies were fundamentally mismatched with the risks they had assumed.
3. Secondary Guarantee Universal Life Insurance
This product included generous guarantees that were based on assumptions about policy cancellations.
Those assumptions proved far too optimistic.
Policyholders held onto valuable contracts, forcing insurers to honor promises that became increasingly expensive in a low-interest-rate environment.
The result was another major wave of reserve charges and balance-sheet stress.
Why Investors Still Distrust Insurance Stocks
Even though many of these risks have been reduced or transferred, investors remain skeptical.
That skepticism shows up clearly in valuations.
Many life insurance companies trade at remarkably low earnings multiples.
Some sell for just four to six times expected earnings.
In many industries, those valuations would attract aggressive buyers.
Instead, investors remain cautious because the industry has a long history of unexpected problems emerging years after products were originally sold.
Long-term care losses, for example, took nearly two decades to fully appear on financial statements.
That kind of history is difficult to forget.
The Rise of Risk Transfer
One major change has been the industry's growing use of risk transfer transactions.
Rather than holding problematic liabilities indefinitely, insurers increasingly transfer risks to specialized firms.
Variable annuity blocks have been sold or reinsured.
Long-term care liabilities have been transferred to reinsurers.
Legacy products are being moved off balance sheets.
The result is that many public insurance companies today are considerably less risky than they were fifteen years ago.
Yet market valuations often fail to reflect that improvement.
Are Insurance Stocks Too Cheap?
This creates an interesting investment question.
If many of these companies have reduced risk and continue generating substantial cash flow, why do they trade at such depressed valuations?
One explanation is that investors simply do not trust the sector.
Another is that insurance has become a relatively ignored corner of the market compared with technology, artificial intelligence, and private credit.
Whatever the reason, some analysts argue that life insurers should be aggressively repurchasing their own shares.
When a company trades at four or five times earnings, buying back stock can create enormous value for remaining shareholders.
Yet many insurers have been cautious, preferring to maintain flexibility and preserve capital.
The Bigger Picture
Private equity's growing role in life insurance is not necessarily a reason for panic.
The largest alternative managers appear disciplined, well-capitalized, and highly experienced in credit markets.
However, the trend does represent a fundamental shift in how insurance companies operate.
The industry is moving away from traditional bond portfolios and toward more sophisticated investment strategies.
That evolution creates opportunities for higher returns, but it also introduces new complexities and risks.
For investors, regulators, and policyholders, the challenge is understanding whether those additional risks are being properly managed.
Final Thoughts
The intersection of private equity and life insurance is one of the most important developments in modern finance.
Supporters see smarter investing, higher returns, and greater efficiency.
Critics see complexity, reduced transparency, and the potential for future surprises.
The truth likely lies somewhere between those extremes.
For now, the evidence suggests that the largest alternative managers are taking more risk than traditional insurers—but not necessarily reckless risk.
The bigger question is whether the market will ever reward traditional insurance companies for the improvements they've already made.
Given that some insurers still trade at valuations rarely seen in other sectors, that may ultimately be the most interesting story of all.
Until next time, this is Steve Eisman, and this has been The Real Eyes Playbook. .
If you’d like to catch my interviews and market breakdowns, visit The Real Eisman Playbook or subscribe to the Weekly Wrap channel on YouTube.
This post is for informational purposes only and does not constitute investment advice. Please consult a licensed financial adviser before making investment decisions.
